Earnings Releases

STEEL PARTNERS HOLDINGS L.P. reported the first quarter ended March 31, 2024 results: revenue $476.3 million, net income $34.8 million, EPS $1.50 per diluted common unit.

“and capital requirements, among others. --- EX-99.2 (EX-99.2) --- Steel Partners Holdings Reports First Quarter Financial Results First Quarter 2024 Results • Revenue was $476.3 million, an increase of 7.0% as compared to the same period in the prior year • Net income was $34.8 million, an increase of 40.3% as compared to the same period in the prior year • Net”

SITIME Corp reported the first quarter ended March 31, 2024 results: revenue $33.0 million, net income GAAP net loss was $28.7 million, EPS $1.26 per diluted share.

“SiTime Corporation, (Nasdaq: SITM), the Precision Timing company, today announced financial results for the first quarter ended March 31, 2024. Net revenue in the first quarter of 2024 was $33.0 million, a 22% decrease from $42.4 million in the prior quarter.”

BIODESIX INC reported the first quarter ended March 31, 2024 results: revenue $14.8 million, net income $13.6 million. Guidance reaffirmed.

“Total revenue of $14.8 million, an increase of 64%”

MRC GLOBAL INC. reported the three months ended March 31, 2024 results: revenue $806 million, net income $13 million, EPS $0.15 per diluted share.

“and was $188 million, or 21.2% of sales, for the first quarter of 2023 . First Quarter 2024 Financial Highlights: ● Cash flow provided by operations of $38 million ● Sales of $806 million, a 5% improvement compared to the fourth quarter of 2023 ● Adjusted Gross Profit, as a percentage of sales, of 21.6% , and eight consecutive quarters above 21% ● Adjusted EBITDA”

Invesco Mortgage Capital Inc. reported the quarter ended March 31, 2024 results: net income Net income per common share of $0.49, EPS $0.49 per common share.

“Invesco Mortgage Capital Inc. (NYSE: IVR) (the “Company”) today announced financial results for the quarter ended March 31, 2024. • Net income per common share of $0.49 compared to $0.46 in Q4 2023”

Mastech Digital, Inc. reported first quarter ended March 31, 2024 results: revenue $46.8 million, net income ($161,000), EPS ($0.01) per diluted share.

“IT Services, announced today its financial results for the first quarter ended March 31, 2024. First Quarter 2024 Highlights: • Total consolidated revenues declined by 15% to $46.8 million, compared to revenues of $55.1 million in the first quarter of 2023. However, total consolidated revenues during the first quarter of 2024 were 2% higher sequentially from the”

ASSEMBLY BIOSCIENCES, INC. reported first quarter ended March 31, 2024 results: revenue $5.8 million, net income $9.1 million, EPS $1.66 per basic and diluted share.

“to $130.2 million as of December 31, 2023. Assembly Bio’s cash position is projected to fund operations into the second half of 2025. • Revenues from collaborative research were $5.8 million for the three months ended March 31, 2024. There was no revenue recognized for the same period in 2023. Revenue for the three months ended March 31, 2024 consists of amounts”

KALTURA INC reported first quarter ended March 31, 2024 results: revenue $44.8 million, net income $11.1 million, EPS $0.08 per diluted share. Guidance reaffirmed.

“bookings, will support our path towards sustainable profitable growth,” concluded Yekutiel. First Quarter 2024 Financial Highlights: • Revenue for the first quarter of 2024 was $44.8 million, an increase of 3% compared to $43.3 million for the first quarter of 2023. • Subscription Revenue for the first quarter of 2024 was $41.2 million, an increase of 2% compared to”

ZEVRA THERAPEUTICS, INC. reported first quarter ended March 31, 2024 results: revenue $3.4 million, net income ($16.6) million, EPS ($0.40) per basic and diluted share.

“patients currently enrolled and to preserve the value of the program while conducting our portfolio review. Overview of Q1 2024 Financial Results: Net revenue for Q1 2024 was $3.4 million, compared to net revenue of $3.2 million in Q1 2023. The components of revenue during the first quarter included $2.2 million in net reimbursements from the French EAP for”

Western Midstream Partners, LP reported first-quarter 2024 results: net income $559.5 million, EPS $1.47 per common unit (diluted). Guidance raised.

“Western Midstream Partners, LP issued a press release announcing first-quarter 2024 results.”

FS KKR Capital Corp reported quarter ended March 31, 2024 results: EPS $0.62.

“On May 8, 2024, FS KKR Capital Corp. (the “Company”) issued a press release (the “Press Release”) providing an overview of its results for the quarter ended March 31, 2024.”

Syndax Pharmaceuticals Inc reported the quarter ended March 31, 2024 results: net income net loss attributable to common stockholders of $72.4 million, EPS $0.85 per share.

“Syndax reported a net loss attributable to common stockholders of $72.4 million, or $0.85 per share, compared to a net loss attributable to common stockholders of $41.1 million, or $0.59 per share, for the comparable prior year period”

DHI GROUP, INC. reported first quarter ended March 31, 2024 results: revenue $36.0 million, net income $1.5 million, or a negative $0.03 per diluted share, EPS a negative $0.03 per diluted share.

“DHX) (“DHI” or the “Company”) today announced financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Highlights (1) ▪ Total revenue was $36.0 million, down 7% year over year. ▪ Total bookings were $48.8 million, down 9% year over year. ▪ Net loss was $1.5 million, or a negative $0.03 per diluted share, a net loss margin of 3%,”

GREENLIGHT CAPITAL RE, LTD. reported first quarter ended March 31, 2024 results: revenue Gross premiums written increased 16.5% to $217.3 million, net income Net income of $27.0 million, or $0.78 per diluted ordinary share, compared to $5.9 million, or $0.17 per diluted ordinar, EPS $0.78 per diluted ordinary share.

“be expressly set forth by specific reference in such filing. --- EX-99.1 (EX-99.1) --- GREENLIGHT RE ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS Strong Premium Growth of 16.5%, Leading to Net income of $27.0 million GRAND CAYMAN, Cayman Islands – May 8, 2024 – Greenlight Capital Re, Ltd. (NASDAQ: GLRE) (“Greenlight Re” or the “Company”) today reported”

GREENLIGHT CAPITAL RE, LTD. reported financial results for the first quarter ended March 31, 2024.

“On May 8, 2024, Greenlight Capital Re, Ltd. (the "Registrant") issued a press release announcing its financial results for the first quarter ended March 31, 2024. A copy of the press release is attached as Exhibit 99.1 to this Form 8-K and incorporated herein by reference.”

Niagen Bioscience, Inc. reported first quarter of 2024 results: revenue $22.2 million, net income $0.5 million, EPS $(0.01) per share. Guidance reaffirmed.

“ChromaDex Corporation Reports First Quarter 2024 Financial Results Total net sales of $22.2 million, gross margin of 60.7%, a net loss of $0.5 million and a positive Adjusted EBITDA of $0.7 million for the three months ended March 31, 2024. Reiterated full year outlook including net sales growth of at least 16%.”

FITLIFE BRANDS, INC. reported preliminary financial results for first quarter 2024.

“together with the Company’s preliminary financial results for the quarter ended March 31, 2024.”

MYOMO, INC. reported first quarter ended March 31, 2024 results: revenue $3.8 million, net income $3.8 million, or $0.10 per share. Guidance raised.

“Record 275 patients in backlog, includes 180 authorizations and orders in Q1, up 48% over the prior year Record 493 MyoPro candidates added to the pipeline in Q1 Revenue of $3.8 million, up 9% over the prior year Conference call begins at 4:30 p.m. Eastern time today BOSTON (May 8, 2024) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable”

Globalstar, Inc. updated its the first quarter ended March 31, 2024 guidance (reaffirmed).

“On May 8, 2024, Globalstar, Inc. (the "Company") issued a press release announcing the Company's financial and operating results for the three months ended March 31, 2024.”

Energy Services of America CORP reported financial results for for the three and six months ended March 31, 2024.

“On May 8, 2024, Energy Services of America Corporation issued a press release disclosing its results of operations and financial condition at and for the three and six months ended March 31, 2024.”

SUPERNUS PHARMACEUTICALS, INC. updated its the first quarter of 2024 guidance (reaffirmed).

“On May 8, 2024, Supernus Pharmaceuticals, Inc. ("Supernus" or the "Company") issued a press release regarding its financial results for the first quarter ended March 31, 2024.”

QVC Group, Inc. reported the quarter ended March 31, 2024 results: net income Net income (loss) $(1), EPS $0.00.

“tomer of women over 50.” ​ First quarter 2024 operating results: ● Qurate Retail revenue decreased 4% (2) in both US Dollars and constant currency (3) ● Qurate Retail grew Adjusted OIBDA (4) 25% (2) in constant currency ● Qurate Retail reported diluted EPS of $0.00 o Adjusted diluted EPS (4) of $0.04 ● QxH revenue decreased 4% ● QVC International revenue decreased 3% o In constant currency, revenue decreased 1% ● Cornerstone revenue decreased 11% ​ ​ Corporate headlines: ​ ● Repaid remaining $423 million principal outstanding of QVC’s 4.85% senior secured notes due April 2024 ​ Discussion of Results ​ Unless otherwise noted, the following discussion compares financial information for the three months ended March 31, 2024 to the same period in 2023.”

Vanda Pharmaceuticals Inc. reported first quarter ended March 31, 2024 results: revenue $47.5 million, net income $(4.1) million.

“Financial Highlights • Total net product sales from Fanapt ® , HETLIOZ ® and PONVORY ® were $47.5 million in the first quarter of 2024, a 24% decrease compared to $62.5 million in the first quarter of 2023, and a 5% increase compared to $45.3 million in the fourth quarter of 2023. • Fanapt ® net product sales were $20.6 million in the first quarter of 2024, a 10% decrease compared to $22.9 million in the first quarter of 2023, and a 9% decrease compared to $22.6 million in the fourth quarter of 2023. • HETLIOZ ® net product sales were $20.1 million in the first quarter of 2024, a 49% decrease compared to $39.6 million in the first quarter of 2023, and a 5% decrease compared to $21.1 million in the fourth quarter of 2023. The decrease relative to the first quarter of 2023 was the result of continued generic competition in the U.S. • PONVORY ® net product sales were $6.8 million in the first quarter of 2024. The acquisition of PONVORY ® from Actelion Pharmaceuticals Ltd. (Janssen), a Joh”

DIRTT ENVIRONMENTAL SOLUTIONS LTD reported the three months ended March 31, 2024 results: revenue $40.8 million, net income $3.0 million.

“First Quarter 2024 Highlights • Revenue of $40.8 million in the first quarter of 2024, up 11% compared to the first quarter of 2023. • Gross profit increased to $14.6 million or 35.9% of revenue in the first quarter of 2024 from $8.7 million or 23.7% of revenue in the first quarter of 2023. • Net income after tax and net income margin for the first quarter of 2024 of $3.0 million and 7.5%, respectively, compared to a net loss after tax of $11.4 million and a net loss margin of 31.1% in the first quarter of 2023.”

Fidelity National Financial, Inc. reported the first quarter ended March 31, 2024 results: revenue $3,299, net income $248 million, EPS $0.91 per diluted share.

“Summary Financial Results (In millions, except per share data) Three Months Ended March 31, 2024 March 31, 2023 Total revenue $ 3,299 $ 2,474 F&G total gross sales 1 $ 3,495 $ 3,281 F&G assets under management 1 $ 49,787 $ 45,311 Total assets $ 84,496 $ 69,654 Adjusted pre-tax title margin 10.7 % 10.0 % Net earnings attributable to common shareholders $ 248 $ (59) Net earnings per share attributable to common shareholders $ 0.91 $ (0.22) Adjusted net earnings 1 $ 206 $ 151 Adjusted net earnings per share 1 $ 0.76 $ 0.56 Weighted average common diluted shares 272 271 Total common shares outstanding 273 272”

GLOBAL PARTNERS LP reported first quarter ended March 31, 2024 results: net income Net loss was $5.6 million, EPS $0.37 per common limited partner unit.

“Net loss was $5.6 million, or $0.37 per common limited partner unit, for the first quarter of 2024 compared with net income of $29.0 million, or $0.70 per diluted common limited partner unit, in the same period of 2023.”

GENCO SHIPPING & TRADING LTD reported the first quarter ended March 31, 2024 results: revenue $117.4 million, net income $18.8 million.

“of $1.8 million, a loss on sale of vessels of $1.0 million and unrealized fuel gains of $0.2 million o Adjusted EBITDA of $41.9 million for Q1 2024 2 • Voyage revenues: Totaled $117.4 million in Q1 2024 o Net revenue 2 was $76.7 million during Q1 2024 o Average daily fleet-wide TCE 2 was $19,219 for Q1 2024 • Estimated TCE to date for Q2 2024: $20,126 for 65% of our”

Federal Home Loan Bank of Cincinnati reported financial results for the quarter ended March 31, 2024.

“On May 8, 2024, the Federal Home Loan Bank of Cincinnati (the FHLB) is holding a member webinar to discuss its financial results for the year ended December 31, 2023 and the quarter ended March 31, 2024”

Federal Home Loan Bank of Cincinnati reported financial results for the year ended December 31, 2023.

“On May 8, 2024, the Federal Home Loan Bank of Cincinnati (the FHLB) is holding a member webinar to discuss its financial results for the year ended December 31, 2023 and the quarter ended March 31, 2024”

GLADSTONE INVESTMENT CORPORATION\DE reported fiscal year ended March 31, 2024 results: revenue $ 87,306, net income 21,777, EPS $ 0.63.

“For the year ended: Total investment income $ 87,306 $ 81,543 $ 5,763 7.1 % Total expenses, net (A) 65,529 44,543 20,986 47.1 % Net investment income (A) 21,777 37,000 (15,223) (41.1) % Net realized gain 30,256 10,753 19,503 181.4 % Net unrealized appreciation (depreciation) 33,272 (12,206) 45,478 NM Net increase in net assets resulting from operations (A) $ 85,305 $ 35,547 $ 49,758 140.0 % Net investment income per weighted-average common share (A) $ 0.63 $ 1.11 $ (0.48) (43.2) %”

GLADSTONE INVESTMENT CORPORATION\DE reported fourth quarter ended March 31, 2024 results: revenue $ 23,648, net income 5,323, EPS $ 0.15.

“For the quarter ended: Total investment income $ 23,648 $ 23,081 $ 567 2.5 % Total expenses, net (A) 18,325 13,337 4,988 37.4 % Net investment income (A) 5,323 9,744 (4,421) (45.4) % Net realized (loss) gain (14,650) 43,461 (58,111) NM Net unrealized appreciation (depreciation) 31,911 (46,626) 78,537 NM Net increase in net assets resulting from operations (A) $ 22,584 $ 6,579 $ 16,005 243.3 % Net investment income per weighted-average common share (A) $ 0.15 $ 0.28 $ (0.13) (46.4) %”

FreightCar America, Inc. reported first quarter ended March 31, 2024 results: revenue $161.1 million, net income ($11.6) million, EPS ($0.54) per share. Guidance reaffirmed.

““Company”), a diversified manufacturer of railroad freight cars, today reported results for the first quarter ended March 31, 2024. First Quarter 2024 Highlights • Revenues of $161.1 million on 1,223 railcar deliveries, an increase of 99% compared to revenues of $81.0 million on 738 railcar deliveries in the first quarter of 2023 • Gross margin of 7.1% with gross”

Everi Holdings Inc. reported the three months ended March 31, 2024 results: revenue $189.3 million, net income $4.6 million, EPS $0.05.

“half of 2024 and position the Company for long-term success." 1 First Quarter 2024 Financial Results Consolidated revenues for the three-month period ended March 31, 2024 were $189.3 million compared to $200.5 million in the year-ago first quarter. Games revenues of $97.1 million were down from the prior year period, and essentially flat on a quarterly sequential”

EyePoint, Inc. reported the first quarter ended March 31, 2024 results: revenue $11.7 million, net income $29.3 million, EPS ($0.55) per share.

“For the first quarter ended March 31, 2024, total net revenue was $11.7 million compared to $7.7 million for the quarter ended March 31, 2023. Net product revenue for the first quarter was $0.7 million, compared to net product revenues for the first quarter ended March 31, 2023 of $7.4 million. This decrease in net product revenue resulted from the out-license of the YUTIQ franchise in May 2023, completing the strategic pivot from a commercial company to a biopharmaceutical pipeline-focused company. Net revenue from royalties and collaborations for the first quarter ended March 31, 2024 totaled $11.0 million compared to $0.3 million in the corresponding period in 2023. This increase was primarily due to partial recognition of deferred revenue from the license of the YUTIQ franchise, which begun in 2Q 2023 and will be recognized over a 2-year period in connection with the delivery of YUTIQ supply units. Operating expenses for the first quarter ended March 31, 2024 totaled $45.0 million”

BRIGHTCOVE INC reported first quarter ended March 31, 2024 results: revenue $50.5 million, net income $1.6 million, EPS $0.04 per diluted share.

“meaningful EBITDA and cash flow,” said Marc DeBevoise, Brightcove’s Chief Executive Officer. First Quarter 2024 Financial Highlights: • Revenue for the first quarter of 2024 was $50.5 million, an increase of 3% compared to $49.1 million for the first quarter of 2023. Subscription and support revenue was $48.0 million, an increase of 2% compared to the first quarter of”

Celanese Corp reported first quarter 2024 results: revenue $2.6 billion, net income $124 million, EPS $1.10.

“Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today reported first quarter 2024 U.S. GAAP diluted earnings per share of $1.10 and adjusted earnings per share of $2.08. The Company generated net sales of $2.6 billion in the quarter”

Amphastar Pharmaceuticals, Inc. reported the three months ended March 31, 2024 results: revenue $171.8 million, net income $43.2 million, EPS $0.81 per share.

“Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (“Amphastar” or the “Company”) today reported results for the three months ended March 31, 2024. ​ First Quarter Highlights ​ ● Net revenues of $171.8 million for the first quarter ● GAAP net income of $43.2 million, or $0.81 per share, for the first quarter”

ORMAT TECHNOLOGIES, INC. reported first quarter ended March 31, 2024 results: revenue $224.2 million, net income $38.6 million, EPS $0.64. Guidance reaffirmed.

“Net income attributable to the Company’s stockholders for the first quarter was $38.6 million, an increase of 32.9% compared to last year. Diluted EPS for the first quarter was $0.64, an increase of 25.5% compared to the prior year period.”

PROFIRE ENERGY INC reported first quarter ending March 31, 2024 results: revenue $13.6 million, net income $1.4 million, EPS $0.03 per diluted share.

“31, 2024. A conference call will be held on Thursday, May 9, 2024 at 8:30 a.m. ET to discuss the results. First Quarter Summary (comparisons to prior-year quarter) • Revenue of $13.6 million, compared to $14.7 million • Gross profit of $6.8 million, compared to $7.8 million • Gross margin of 49.5%, compared to 53.3% • Net income of $1.4 million, or $0.03 per diluted”

PROSPECT CAPITAL CORP reported fiscal quarter ended March 31, 2024 results: revenue $94,375, net income $113,891, EPS $0.27.

“amounts (on weighted average basis for period numbers) Quarter Ended Quarter Ended Quarter Ended March 31, 2024 December 31, 2023 March 31, 2023 Net Investment Income (“NII”) $94,375 $96,927 $102,180 NII per Common Share $0.23 $0.24 $0.26 Interest as % of Total Investment Income 91.0% 92.3% 92.1% Net Income (Loss) Applicable to Common Shareholders $113,891”

NOODLES & Co reported first quarter ended April 2, 2024 results: revenue $121.4 million, net income $6.1 million loss, EPS $0.14 loss per diluted share.

“results for its first quarter ended April 2, 2024. Key highlights for the first quarter of 2024 versus the first quarter of 2023 include: • Total revenue decreased 3.7% to $121.4 million from $126.1 million in the first quarter of 2023. • Comparable r estaurant sales decreased 5.4% system-wide, comprised of a 5.7% decrease at company-owned restaurants and a 4.5%”

IMMUNIC, INC. reported financial results for the first quarter ended March 31, 2024.

“On May 8, 2024, Immunic, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended March 31, 2024 and providing a corporate update”

B&G Foods, Inc. reported Full Year Fiscal 2024 results: revenue $1.955 billion to $1.985 billion, EPS $0.75 to $0.95.

“Guidance for Full Year Fiscal 2024 ● Net sales revised to a range of $1.955 billion to $1.985 billion. ● Adjusted EBITDA revised to a range of $300 million to $320 million. ● Adjusted diluted earnings per share revised to a range of $0.75 to $0.95.”

B&G Foods, Inc. reported first quarter of 2024 results: revenue $475.2 million, net income $(40.2) million, EPS $(0.51) per diluted share.

“and clarify the portfolio for sharper focus and fit.” Financial Results for First Quarter of 2024 Net sales for the first quarter of 2024 decreased $36.6 million, or 7.1%, to $475.2 million from $511.8 million for the first quarter of 2023. The decrease was primarily attributable to the Green Giant U.S. shelf-stable divestiture, a decrease in net pricing, the impact”

Energy Transfer LP reported first fiscal quarter ended March 31, 2024 results: net income $1.24 billion, EPS $0.32. Guidance raised.

“Energy Transfer reported net income attributable to partners for the three months ended March 31, 2024 of $1.24 billion. For the three months ended March 31, 2024, net income per common unit (basic) was $0.32.”

AIRGAIN INC reported first quarter ended March 31, 2024 results: revenue $14.2 million, net income GAAP net loss of $2.5 million, EPS $(0.23) per share.

“growth as we continue to effectively navigate a challenging macro-economic environment,” said Airgain’s President and Chief Executive Officer, Jacob Suen. “We delivered sales of $14.2 million in the first quarter, driven by sequential and year-over-year revenue growth in our enterprise market. As we look to the rest of 2024, we remain focused on the launch of our 5-G”

KRONOS WORLDWIDE INC reported First Quarter 2024 results: revenue $478.8 million, net income $8.1 million, EPS $.07 per share.

“production costs (primarily energy and raw material costs). Comparability of our results was also impacted by the effects of changes in currency exchange rates. ​ Net sales of $478.8 million in the first quarter of 2024 were $52.5 million, or 12%, higher than in the first quarter of 2023. Net sales increased in the first quarter of 2024 compared to the first quarter”

MARINUS PHARMACEUTICALS, INC. reported first quarter ended March 31, 2024 results: revenue $7.5 million. Guidance raised.

“(EX-99.1) --- ​ Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results ​ ● ZTALMY ® (ganaxolone) Q1 2024 net product revenue of $7.5 million representing strong growth of 125% versus Q1 2023 ● Increased full year 2024 projected U.S. ZTALMY net product revenues to between $33 and $35 million ● Enrollment to be”

UNIVERSAL TECHNICAL INSTITUTE INC reported the fiscal 2024 second quarter ended March 31, 2024 results: revenue $184.2 million, net income $7.8 million, EPS $0.14. Guidance raised.

“Institute (UTI) and Concorde Career Colleges (Concorde), and together with its segments and subsidiaries is referred to as the “Company,” “we,” “us” or “our.” • Reven ue of $184.2 million representing 12.4% growth versus the prior year period, with UTI and Concorde achieving 14.7% and 8.2% growth versus the prior year period, respectively. • Total new student”

MARCHEX INC reported first quarter ended March 31, 2023 results: EPS adjusted non-GAAP loss per share was ($0.08).

“Net loss was $1.5 million for the first quarter of 2024 or $0.03 per diluted share, compared to a net loss of $4.5 million or $0.11 per diluted share for the first quarter of 2023.”